Swiss National Bank Icosavax, Inc. Transaction History

Swiss National Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$5.7 - $10.33 $157,890 - $286,141	-27,700 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$4.41 - $22.5 $7,056 - $36,000	1,600 Added 6.13%	27,700 $195,000
Q4 2021 Feb 08, 2022	BUY	$21.07 - $34.98 $549,927 - $912,977	26,100 New	26,100 $597,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.